Latest Research Reports

PMDA approvals pivot to oncology

PMDA approvals pivot to oncology

Acute Myeloid Leukemia: noticeable differences in subtypes by age

Acute Myeloid Leukemia: noticeable differences in subtypes by age

A success story: the human papillomavirus vaccine

A success story: the human papillomavirus vaccine

Bispecific antibodies and CAR-T cells: A comparison of historical trial numbers and patient recruitment

Bispecific antibodies and CAR-T cells: A comparison of historical trial numbers and patient recruitment

Epidemiology of Heamophilia: a rare hereditary bleeding disorder

Epidemiology of Heamophilia: a rare hereditary bleeding disorder

Risk of Venous thromboembolism higher in ageing population

Risk of Venous thromboembolism higher in ageing population

HER2 expression associated with poorer prognosis, but found more frequently in non-invasive breast cancer

HER2 expression associated with poorer prognosis, but found more frequently in non-invasive breast cancer

US Sees High Rates of Ovarian Cancer Diagnosed at Stage IV

US Sees High Rates of Ovarian Cancer Diagnosed at Stage IV

Type 2 Diabetes Leads Indications in Russian Clinical Trials, 2012-2016

Type 2 Diabetes Leads Indications in Russian Clinical Trials, 2012-2016

The need for action: improving awareness and early diagnosis of SLE

The need for action: improving awareness and early diagnosis of SLE

Geographical variations in spondyloarthropathies prevalence related to HLA-B27 Prevalence

Geographical variations in spondyloarthropathies prevalence related to HLA-B27 Prevalence

Urban China stands out from US, major European markets and Japan when comparing invasive breast cancer HER2 status

Urban China stands out from US, major European markets and Japan when comparing invasive breast cancer HER2 status

Recent failures in Alzheimer’s Research and Development (R&D)

Recent failures in Alzheimer’s Research and Development (R&D)

FDA approval of siliq for psoriasis – how will the drug perform in an already overcrowded market?

FDA approval of siliq for psoriasis – how will the drug perform in an already overcrowded market?

Targeted therapies will radically improve head and neck cancer treatment

Head and neck cancer (HNC) is the sixth most common cancer worldwide, and the majority of available treatments are highly toxic...

Targeted therapies will radically improve head and neck cancer treatment